Form 4: Natera Executive Sells Shares to Cover Tax Obligations

Natera's President of Clinical Diagnostics, Solomon Moshkevich, sold shares to cover tax obligations related to vesting of Restricted Stock Units (RSUs).

Summary

• Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold a total of 24,861 shares of common stock on January 22, 2025.
• The sales were executed to cover tax withholding obligations associated with the vesting of RSUs.
• The shares were sold at a weighted average price of $164.9488 for 24,799 shares and a weighted average price of $171.9542 for 62 shares.
• The sales were made under a pre-arranged 10b5-1 trading plan.
• Following the transactions, Moshkevich directly owns 140,684 shares of Natera common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for an executive to cover tax obligations, which is neither positive nor negative for the company's overall outlook.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when RSUs vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The use of 10b5-1 trading plans is a standard method for executives to avoid accusations of insider trading.
• Similar transactions are regularly reported by executives at comparable companies in the biotech and diagnostics sectors.

Stakeholder Impact

• The stock sale has a minimal impact on shareholders as it is a routine transaction for tax purposes.

Key Dates

Keywords

Natera, insider trading, Form 4, stock sale, RSU, Solomon Moshkevich, tax obligations, 10b5-1 plan